Prenatal lack of omega 3 and omega 6 linked to schizophrenic symptoms in offspring

ab2e11d2-b2e0-49ac-adb1-0a481f5589faarticleimage.jpg

06 Sep 2017 --- Researchers have discovered a process through which changes in nutrition during early mouse pregnancy lead to offspring that develop schizophrenic-like symptoms as adults. Published in Translational Psychiatry, the study from the RIKEN Brain Science Institute in Japan shows how deprivation of two polyunsaturated fatty acids during early gestation can have long-lasting effects on offspring through specific changes in gene expression.

Harmful conditions during pregnancy are known to affect the health status of offspring, even resulting in adult-onset diseases – for example, prenatal alcohol exposure has been linked to an increase in the likelihood of addiction. This concept – known as the Development Origin of Health and Disease (DOHaD) – could explain why rates of schizophrenia have been observed to double after famines, the RIKEN press release points out.

In order to develop effective treatments for schizophrenia, Takeo Yoshikawa and his team at RIKEN report that they are researching exactly how malnutrition during early development changes the brain.

“Our work is the first in the field of psychiatry to identify a molecular cascade that links nutritional environment to disease risk in the context of the DOHaD paradigm,” study first author Motoko Maekawa notes.

Linking nutrients to schizophrenia
The first step to figuring out the “how” of the study was to determine the most likely nutrient whose deficiency is related to schizophrenia. The team chose to study two specific polyunsaturated fatty acids – the omega 3 fatty acid DHA and the omega 6 fatty acid AA – because they are abundant in the brain and are known to be related to brain development. RIKEN reports that the team tested their theory by depriving pregnant mice of DHA and AA and testing whether their adult offspring shared characteristics shown by people with schizophrenia.

People in the early stages of schizophrenia have several common symptoms, including low levels of motivation, depression, impaired memory and abnormal brain function in the prefrontal cortex. The adult mice whose mothers were deprived of DHA and AA showed similar symptoms.

As dysfunction in the prefrontal cortex is a hallmark of schizophrenia, the team reports that it looked next at how DHA and AA deprivation affects gene expression in that part of the brain. Among the hundreds of affected genes, they found a group of genes downregulated in people with schizophrenia that were also downregulated in the affected mice. These genes are related to oligodendrocytes, cells in the brain that surround neurons and help the transmission of signals in the brain.

Additionally, expression of genes affecting the gamma-aminobutyric acid (GABA) neurotransmitter system were altered in ways that mimicked findings from the postmortem brains of people with schizophrenia.

Gene expression can be controlled by a certain class of proteins called nuclear receptors that attach to DNA and initiate the transcription process that builds proteins from the DNA code. When the team conducted further analysis of the fatty-acid deprived mice, they found several nuclear receptor genes related to fatty acids had been downregulated.

The abnormal expression of oligodendrocyte-related genes could be traced directly back to the low expression of these nuclear receptors, which in turn could be traced back to higher levels of DNA methylation, a common way to regulate gene expression. In this way, it was found that the altered diet succeeded in creating long-lasting changes in gene expression.

The results of the prenatal study come at a time when it has already been suggested that the prenatal supplements industry should review product formulations. Meanwhile, omega 3 and omega 6 continue to be linked with positive health claims, as was shown when Bunge’s soybean health oil claim was approved by the US FDA based on a petition that included a summary of recent major clinical studies showing the potential benefits of soybean oil to heart health. The petition was based partly on its high concentration of polyunsaturated omega 6 and omega 3 fatty acids versus other oils and fats

The study, “Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes,” is published in Trans Psychiatry.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

Taiyo: Tapping into tea's health benefits

22 May 2018 --- Manufacturer of functional ingredients Taiyo presented its Sunphenon teas and Xia Oil as convenient, safe and suitable for a range of applications at Vitafoods last week. Taiyo also exhibited plans to further increase knowledge around tea as a health drink and their innovative beverage combinations with lasting Taiyo ingredients such as Sunfiber. The products in question can be used in an array of drinks applications, packing health punches that range from omega 3 boosts to fiber enrichment. They also target a number of factors including cardiovascular and glycemic health.

Nutrition & Health News

Weekly Digest: Valensa's Saw Palmetto gains sustainable logo

18 May 2018 --- The past week saw Valensa International gain sustainable recognition with the Fresh from Florida logo for their Saw Palmetto product, as well as USP’s (United States Pharmacopeia) Dietary Supplement Verification Program nabbing the top spot for reliability as determined by pharmacists in a survey conducted by the Pharmacy Times. Furthermore, in clinical news, omega 3 and omega 6 were found to aid the regulation of blood glucose levels in rats. The findings open up the potential for the use of supplements in type 2 diabetes regulation.

Nutrition & Health News

BGG & Solix Algredients combine to expand functional ingredient NPD and portfolio

18 May 2018 --- BGG and Solix Algredients, Inc. have joined forces to form a new company supplying functional ingredients originating from three sectors: algae, fruits and plants. The new company hopes for particular strength in innovative product combinations and the natural astaxanthin market. The portfolio will include natural astaxanthin, DHA Omega-3 fatty acids, Vitamin E tocotrienols, apple polyphenols and fruit/berry extracts for the food/beverage, personal care and feed markets. 

Nutrition & Health News

Glanbia targets modern lifestyle demands with new performance nutrition ingredients 

17 May 2018 --- Glanbia Nutritionals has launched two new performance nutrition ingredients for formulation in functional beverages in Europe, the Middle East and Africa. Ignitor and WheyXR were developed to enhance amino acid release, allowing manufacturers to maximize the health benefits of protein supplementation. Both ingredients target the ever-expanding market for sports nutrition options and were included in its range of prototypes at this year’s Vitafoods Europe 2018, which showcased Glanbia’s portfolio and applications expertise.

Nutrition & Health News

Golden spice: Turmeric finds appeal in organic NPD

11 May 2018 --- Touting a vast array of health benefits, turmeric has been trending for quite some months now. The golden spice was one of the standout trends at Vitafoods Europe 2017, and it has since made its way into a wide range of food and beverages launched over the past year. The application of turmeric was a standout theme at this year’s Natural and Organic Products show in London held the end of April. NutritionInsight looks at some of the offerings on show.

More Articles
URL : http://www.nutritioninsight.com:80/news/prenatal-lack-of-omega-3-and-omega-6-linked-to-schizophrenic-symptoms-in-offspring.html